• DMH1: Selective BMP Type I Receptor Inhibitor for Organoi...

  2025-10-22

  DMH1 empowers researchers to selectively modulate BMP signaling in organoid engineering and non-small cell lung cancer models, driving breakthroughs in cell fate control and tumor suppression. Its robust specificity for ALK2 and ALK3 ensures reproducible, high-throughput experimental outcomes while minimizing off-target effects. Discover protocol optimizations, comparative insights, and troubleshooting strategies to maximize DMH1's impact in applied biomedical workflows.

• Torin2: Selective mTOR Inhibitor Workflows for Cancer Res...

  2025-10-21

  Torin2, a highly selective and cell-permeable mTOR inhibitor, is transforming cancer research by enabling precise dissection of PI3K/Akt/mTOR signaling and apoptosis beyond transcriptional regulation. This guide delivers proven experimental workflows, advanced applications, and troubleshooting strategies for maximizing Torin2’s impact in cellular and in vivo models.

407 records 28/28 page Previous First page 上5页 262728